New cancer clinical trial: Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer

Published on: June 25, 2018 at 12:00PM
Condition:   mCRC
Interventions:   Drug: Irinotecan;   Drug: Oxaliplatin
Sponsors:   Peking University;   Liaoning Tumor Hospital & Institute;   Zhejiang University
Active, not recruiting
https://ift.tt/2Mr1LD5